Your AI Model Passed Validation But Your FDA Audit Didn't—Here's Why

A model may perform exceptionally well and still lack the evidence package necessary to support regulatory review.
ascopubs.org

Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...